A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 35/76 (2006.01)
Patent
CA 2761659
Described is a parvovirus for preventing recurrence of a tumor, preferably a malignant brain tumor or pancreas tumor.
Le parvovirus ci-décrit permet de prévenir la récidive d'une tumeur, de préférence, une tumeur maligne du cerveau ou une tumeur du pancréas.
Aprahamian Marc
Geletneky Karsten
Grekova Svitlana
Kiprijanova Irina
Koch Ute
Benoit & Cote Associes Inc.
Deutsches Krebsforschungszentrum Stiftung Des Oeffentlichen Rech
Ruprecht-Karls-Universitaet Heidelberg
LandOfFree
Oncolytic virotherapy for prevention of tumor recurrence does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Oncolytic virotherapy for prevention of tumor recurrence, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oncolytic virotherapy for prevention of tumor recurrence will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1426430